What is the recommended postoperative medication regimen for a patient after a ball joint hip replacement?

Postoperative Medication Regimen for Hip Replacement

For venous thromboembolism (VTE) prophylaxis after hip replacement, use enoxaparin 30 mg subcutaneously twice daily starting 12 hours after surgery, continued for 10-14 days with consideration for extension up to 35 days, combined with a multimodal pain management regimen consisting of scheduled paracetamol, NSAIDs/COX-2 inhibitors, intravenous dexamethasone 8-10 mg intraoperatively, and regional analgesia (fascia iliaca block or pericapsular nerve group block). 1, 2, 3

VTE Prophylaxis (Primary Concern for Mortality/Morbidity)

The most critical postoperative medication consideration is preventing venous thromboembolism, which directly impacts mortality and major morbidity:

Standard Anticoagulation Protocol

• Enoxaparin 30 mg subcutaneously twice daily starting 12 hours after surgery 1
  • Continue for minimum 10-14 days
  • Extend to 35 days for optimal protection 1
  • Alternative: Enoxaparin 40 mg once daily (European dosing)

Alternative Anticoagulants

• Rivaroxaban 10 mg once daily starting 6-10 hours postoperatively 1

  • Continue 10-14 days, consider extending to 35 days
  • FDA-approved specifically for hip arthroplasty VTE prophylaxis
  • Contraindicated if CrCl <30 mL/min

• Fondaparinux 2.5 mg subcutaneously once daily 1

  • Reduce to 1.5 mg if CrCl 30-50 mL/min
  • Same duration as enoxaparin

Critical timing consideration: Do not resume therapeutic-dose anticoagulation too early. For patients on chronic anticoagulation requiring bridging, resume therapeutic LMWH only at 48 hours post-surgery once hemostasis is assured. Prophylactic-dose LMWH can begin at 12 hours. 1

Pain Management (Quality of Life Priority)

Core Analgesic Regimen (Start Pre/Intraoperatively)

Basic analgesics form the foundation - these should be scheduled, not PRN:

• Paracetamol (Acetaminophen): 1000 mg every 6 hours 2, 3

  • Oral and IV formulations equally effective despite cost difference 4
  • Continue throughout hospitalization

• NSAIDs or COX-2 Selective Inhibitors 2, 3

  • Strong evidence supports use for opioid-sparing effect 4
  • Continue postoperatively on scheduled basis
  • Monitor for bleeding risk, especially with concurrent anticoagulation

• Intravenous Dexamethasone 8-10 mg (single intraoperative dose) 2, 3

  • Provides both analgesic and anti-emetic effects
  • Do not exceed 10 mg

Regional Analgesia (Choose One)

The 2026 updated PROSPECT guidelines prioritize motor-sparing blocks:

Preferred options (in order):

1. Supra-inguinal fascia iliaca compartment block 3
2. Pre-operative pericapsular nerve group (PENG) block 3
3. Single-shot local infiltration analgesia (if regional techniques unavailable) 2, 3

Not recommended due to motor weakness risk:

• Quadratus lumborum block 3
• Lumbar erector spinae plane block 3
• Femoral nerve block (excessive motor block) 2
• Epidural analgesia (adverse effects outweigh benefits) 2

Intrathecal Morphine (If Spinal Anesthesia Used)

• 0.1 mg intrathecal morphine may be considered 2, 3
• Caution: PROSPECT emphasizes risks and side-effects
• Only use in hospitalized patients with appropriate monitoring
• Adequate analgesia often achievable without this option 2

Rescue Analgesia

• Opioids reserved for breakthrough pain only 2, 3
• Avoid scheduled opioid regimens
• Tramadol combined with metoclopramide reduces nausea risk if opioids needed 5

Adjunctive Medications

Intravenous Ketamine:

• Strong evidence for decreased opioid use in first 24 hours 4
• Consider for perioperative period

NOT Recommended:

• Gabapentinoids: No significant benefit demonstrated for pain or opioid reduction 2, 4
• Duloxetine: Insufficient evidence in perioperative period 4

Special Considerations for Patients on Chronic Anticoagulation

Resuming Anticoagulation Post-Surgery

For patients on chronic anticoagulation (e.g., atrial fibrillation):

High bleeding risk surgery (hip replacement qualifies):

• Dabigatran: Resume 2-3 days (48-72 hours) post-surgery at 150 mg twice daily 6

  • For high thromboembolism risk: consider reduced dose (110-150 mg once daily) on evening after surgery 6

• Rivaroxaban: Resume 2-3 days post-surgery at 20 mg once daily 6

  • Alternative: 10 mg once daily for first 2 days, then increase to 20 mg 6

• Apixaban: Resume 2-3 days post-surgery at 5 mg twice daily 6

  • Consider 2.5 mg twice daily initially if high thromboembolism risk 6

Common Pitfalls to Avoid

1. Starting therapeutic anticoagulation too soon: Wait 48-72 hours for therapeutic doses; bleeding complications outweigh thrombotic risk in immediate postoperative period 6, 1, 6

2. Stopping VTE prophylaxis at hospital discharge: Extended prophylaxis to 35 days significantly reduces late VTE events 1

3. Using PRN-only analgesics: Scheduled multimodal analgesia prevents pain escalation better than reactive treatment 2, 3

4. Relying on motor-blocking regional techniques: Newer motor-sparing blocks (PENG, supra-inguinal fascia iliaca) facilitate early mobilization 3

5. Combining NSAIDs with anticoagulation without monitoring: While both are recommended, requires vigilance for bleeding 1, 2

6. Using gabapentinoids routinely: Despite historical use, current evidence does not support benefit 2, 4